Secondary Logo

Journal Logo

Letters to the Editor

Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy

Chhablani, Jay Kumar; Narula, Ritesh; Narayanan, Raja

Author Information
Indian Journal of Ophthalmology: January 2014 - Volume 62 - Issue 1 - p 97
doi: 10.4103/0301-4738.126197
  • Open

Dear Editor,

We thank the authors for their comments. We agree with the comments regarding other treatment options for polypoidal choroidal vasculopathy (PCV). PDT may be considered alone or in combination with anti-vascular endothelial growth factor (VEGF) drugs. However, anti-VEGF drugs alone also have a significant effect on visual improvement as shown in various studies. As mentioned by the authors, we agree that closure of polyps is an important long-term outcome. In our study, we reported 6 months’ results of anti-VEGF monotherapy. Further studies investigating long-term outcome are warranted.

© 2014 Indian Journal of Ophthalmology | Published by Wolters Kluwer – Medknow